US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist

2.500
+0.320+14.68%

Close Oct 31 16:00 ET

2.608
+0.108+4.33%

Post 20:01 ET

63.84MMarket Cap-1908P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gain Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 14.000K	--
--	2024/Q3	-- / 6.000K	--
--	2024/Q2	0.000 / 240.000K	--
--	2024/Q1	0.000 / 90.000K	--
--	2023/Q4	0.000 / 260.000K	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 14.000K--

--2024/Q3-- / 6.000K--

--2024/Q20.000 / 240.000K--

--2024/Q10.000 / 90.000K--

--2023/Q40.000 / 260.000K--

Unlock Free Earnings Estimates

Open Account

Gain Therapeutics Earnings Reports

Gain Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 16:57 ET

Gain Therapeutics | 10-Q: Q1 2024 Earnings Report

May 14 16:10 ET

Gain Therapeutics | 10-K: FY2023 Annual Report

Mar 26 16:12 ET

Gain Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 14, 2023 16:05 ET

Analyst Rating

Updated: Oct 31, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall